Arbutus Biopharma (ABUS) Shares Outstanding (Entity) (2010 - 2026)

Arbutus Biopharma (ABUS) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Arbutus Biopharma 922.95 Mn 830.33 Mn - 197.63 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 197.63 Mn
Mar 31, 2026 196.95 Mn
Dec 31, 2025 192.53 Mn
Sep 30, 2025 191.95 Mn
Jun 30, 2025 191.64 Mn
Mar 31, 2025 191.48 Mn
Dec 31, 2024 189.96 Mn
Sep 30, 2024 189.44 Mn
Jun 30, 2024 188.74 Mn
Mar 31, 2024 180.19 Mn
Dec 31, 2023 169.87 Mn
Sep 30, 2023 167.70 Mn
Jun 30, 2023 166.92 Mn
Mar 31, 2023 165.13 Mn
Dec 31, 2022 157.46 Mn
Sep 30, 2022 152.71 Mn
Jun 30, 2022 148.79 Mn
Mar 31, 2022 148.73 Mn
Dec 31, 2021 106.24 Mn
Sep 30, 2021 110.26 Mn